Given the critical role of TGF-β/Smad signaling in promoting RF, this review explores the anti-RF effects of TCM by targeting the TGF-β/Smad signaling pathway to delay the progression of CKD and identify more effective clinical agents for RF. Here, TGFB1 is linked to chronic kidney disease.